Opioids Market Size, Top Players, and Forecast by 2031
Opioids Market: Size and Share
-
CAGR (2023 - 2031)1.9% -
Market Size 2023
US$ 12.93 Billion -
Market Size 2031
US$ 15.03 Billion
Market Dynamics
- Rising Geriatric population
- Increasing Government Initiatives Focusing on the Development of Medication to Prevent and Treat Opioid Use Overdose and Disorder
- Strategic Initiatives by Market Players
Market Segmentation
- Immediate-Release Short-Acting Opioids
- Extended-Release Long-Acting Opioid
- Pain Management
- Anaesthesia
- Diarrhoea Suppression
- Cough Suppression
- De-Addiction
- Oral
- Injectable
- Transdermal Patch
- Hospital Pharmacies
- Retail Pharmacies
Opioids Market Players Density: Understanding Its Impact on Business Dynamics
The Opioids Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Opioids Market are:
- Purdue Pharma LP
- Endo International plc
- Mallinckrodt Plc
- Collegium Pharmaceutical Inc
- Neuraxpharm Pharmaceuticals SL
- Hikma Pharmaceuticals Plc
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Opioids Market top key players overview